Chairman, President & CEO of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI), Mates Sharon, sells 27,847 shares worth $1,092,436
According to Intra-Cellular Therapies, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Feb 22 08:01 PM, company Chairman, President & CEO, Mates Sharon disclosed selling 27,847 shares at a cost of $39.23. At the time of this transaction (Feb 19), this trade was worth $1,092,436 in total. As of Feb 19, Mates Sharon now owns 1,133,392 shares in total worth about $44,168,286.24.
For the last few recent trades made by Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) Chairman, President & CEO, Mates Sharon, we have the following information:
- SEC Form 4 filing: Jan 11: Sold 41,896 shares at the rate of $32.01 per share. Total worth of this trade was $1,341,260. Total number of shares owned as of Jan 11 were 1,133,392
- SEC Form 4 filing: Jan 04: Sold 48,341 shares at the rate of $31.30 per share. Total worth of this trade was $1,513,271. Total number of shares owned as of Jan 04 were 1,133,392
- SEC Form 4 filing: Nov 10: Sold 50,000 shares at the rate of $26.34 per share. Total worth of this trade was $1,317,101. Total number of shares owned as of Nov 10 were 1,113,392
Posted by
George Daniels
on Monday February 22 2021, 11:53 PM EDT.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
